Trichuris Suis Ova in Autism Spectrum Disorders

Trial Profile

Trichuris Suis Ova in Autism Spectrum Disorders

Completed
Phase of Trial: Phase I

Latest Information Update: 23 Jul 2014

At a glance

  • Drugs Trichuris suis ova (Primary)
  • Indications Autistic disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Jun 2014 Primary endpoint (Aberrant Behavior Checklist - irritability) has not been met, as reported in a Coronado Biosciences media release.
    • 26 Jun 2014 Results will be presented at the 27th Annual Congress of the European College of Neuropsychopharmacology.
    • 26 Jun 2014 Status changed from active, no longer recruiting to completed, based on a Coronado Biosciences media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top